Quick Answer
Xenetic Biosciences, Inc. reported Operating Income Loss of -$2.83 million for the year ending 2025.
- Xenetic Biosciences, Inc. showed an increase of +32.6% in Operating Income Loss from 2024 to 2025.
- This data is from Xenetic Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2011 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2013: $18.2 thousand | Q1 2013: -$1.39 million | Q2 2013: -$10.3 thousand | Q2 2013: -$1.03 million | Q3 2013: -$2.53 million | Q4 2013: -$76.8 thousand | Q1 2014: -$2.96 million | Q2 2014: -$2.64 million | Q3 2014: -$3.11 million | Q1 2015: -$1.97 million | Q2 2015: -$1.36 million | Q3 2015: -$3.80 million | Q1 2016: -$1.85 million | Q2 2016: -$43.26 million | Q3 2016: -$2.25 million | Q1 2017: -$2.86 million | Q2 2017: -$2.90 million | Q3 2017: -$2.24 million | Q1 2018: -$1.83 million | Q2 2018: -$1.99 million | Q3 2018: -$1.81 million | Q1 2019: -$1.33 million | Q2 2019: -$1.38 million | Q3 2019: -$8.95 million | Q1 2020: -$1.23 million | Q2 2020: -$982.5 thousand | Q3 2020: -$10.50 million | Q1 2021: -$1.37 million | Q2 2021: -$1.13 million | Q3 2021: -$1.38 million | Q1 2022: -$1.62 million | Q2 2022: -$2.69 million | Q3 2022: -$847.8 thousand | Q1 2023: -$915.2 thousand | Q2 2023: -$1.20 million | Q3 2023: -$1.15 million | Q1 2024: -$1.27 million | Q2 2024: -$1.34 million | Q3 2024: -$499.5 thousand | Q1 2025: -$942.4 thousand | Q2 2025: -$724.4 thousand | Q3 2025: -$544.7 thousand.
- Over the full 16 years of available data (2011 to 2025), Xenetic Biosciences, Inc.'s Operating Income Loss has declined by 38,335.0%.
- Historical annual values: Fiscal year 2025: -$2.83 million | Fiscal year 2024: -$4.20 million | Fiscal year 2023: -$4.52 million | Fiscal year 2022: -$6.72 million | Fiscal year 2021: -$5.75 million | Fiscal year 2020: -$13.94 million | Fiscal year 2019: -$12.89 million | Fiscal year 2018: -$7.28 million | Fiscal year 2017: -$3.57 million | Fiscal year 2016: -$47.43 million | Fiscal year 2015: -$9.82 million | Fiscal year 2014: -$12.92 million | Fiscal year 2013: -$8.55 million | Fiscal year 2013: -$65.6 thousand | Fiscal year 2012: -$116.7 thousand | Fiscal year 2011: -$7.4 thousand.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: